Latest Conference Articles

Use of Alendronate Could Lower Odds of Developing Type 2 Diabetes

September 28, 2021

An analysis of patient data from a national registry in Denmark indicates use of alendronate was associated with reductions in odds of developing type 2 diabetes, with this reduction becoming greater with longer use of the osteoporosis medication.

Cardiovascular Care for Women with Diabetes Lagging Behind Care for Men

September 27, 2021

A posthoc analysis of the REWIND trial is providing insight into the overall standard of care seen with women with diabetes and increased cardiovascular risk compared to their male counterparts with diabetes and increased cardiovascular risk.